Literature DB >> 10025947

Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing alpha1d-adrenoceptors.

J A García-Sáinz1, M E Torres-Padilla.   

Abstract

In rat-1 fibroblasts stably expressing alpha1d-adrenoceptors BMY 7378, phentolamine, chloroethylclonidine and 5-methyl urapidil decreased basal [Ca2+]i. WB 4101 induced a very small effect on this parameter but when added before the other antagonists it blocked their effect. All these agents inhibited the action of norepinephrine. Phorbol myristate acetate also blocked the effect of norepinephrine and decreased basal [Ca2+]i. Staurosporine inhibited these effects of the phorbol ester. Our results suggest that: (1) alpha1d-adrenoceptors exhibit spontaneous ligand-independent activity, (2) BMY 7378, phentolamine, chloroethylclonidine and 5-methyl urapidil act as inverse agonists and (3) protein kinase C activation blocks spontaneous and agonist-stimulated alpha1d-adrenoceptor activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025947     DOI: 10.1016/s0014-5793(98)01738-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Signaling properties of human alpha(1D)-adrenoceptors lacking the carboxyl terminus: intrinsic activity, agonist-mediated activation, and desensitization.

Authors:  C Ekaterina Rodríguez-Pérez; M Teresa Romero-Avila; Guadalupe Reyes-Cruz; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-21       Impact factor: 3.000

Review 2.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

3.  Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats.

Authors:  Regina Gisbert; Khalid Ziani; Raquel Miquel; M Antonia Noguera; M Dolores Ivorra; Elsa Anselmi; Pilar D'Ocon
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Addition of a signal peptide sequence to the alpha1D-adrenoceptor gene increases the density of receptors, as determined by [3H]-prazosin binding in the membranes.

Authors:  Ramona Petrovska; Ivo Kapa; Janis Klovins; Helgi B Schiöth; Staffan Uhlén
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

5.  Inverse agonism and neutral antagonism at a constitutively active alpha-1a adrenoceptor.

Authors:  J Zhu; T Taniguchi; R Takauji; F Suzuki; T Tanaka; I Muramatsu
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats.

Authors:  Li Zhang; Takanobu Taniguchi; Takashi Tanaka; Kazumasa Shinozuka; Masaru Kunitomo; Masahiko Nishiyama; Koji Kamata; Ikunobu Muramatsu
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Phosphorylation and desensitization of alpha1d-adrenergic receptors.

Authors:  J A García-Sáinz; F G Vázquez-Cuevas; M T Romero-Avila
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

8.  α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes.

Authors:  Garrett A Enten; Xianlong Gao; Hannah R Strzelinski; McWayne Weche; Stephen B Liggett; Matthias Majetschak
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-10       Impact factor: 12.779

9.  Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.

Authors:  Regina Gisbert; Yolanda Madrero; Valentina Sabino; M Antonia Noguera; M Dolores Ivorra; Pilar D'Ocon
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 10.  The α1-adrenergic receptors: diversity of signaling networks and regulation.

Authors:  Susanna Cotecchia
Journal:  J Recept Signal Transduct Res       Date:  2010-10-18       Impact factor: 2.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.